The Protein Myth: Why Protein Supplements Don’t Build Muscle in Older Adults — And What Actually Does
Walk into any pharmacy, health food store, or supermarket in the United States today and you will find whey protein fortified into everything from breakfast cereals and pasta to tortilla chips and flavored milk. The implicit promise printed on each package is the same: more protein equals more muscle. For the hundreds of millions of people past the age of sixty-five who are quietly losing muscle mass every year, that promise carries genuine emotional weight. It speaks to independence, to mobility, to the ability to climb stairs without holding the railing. A new study from one of America’s most respected nutrition science institutions has now tested that promise with rigorous precision — and found it wanting.
In May 2026, researchers at Tufts University published the results of a well-designed factorial randomized controlled trial in The American Journal of Clinical Nutrition, one of the field’s most authoritative publications. Their conclusion was unambiguous: older adults who already consume an adequate amount of protein in their daily diets gain no additional muscle mass or strength by supplementing with whey protein. The findings do not simply tweak existing guidance — they directly challenge a multi-billion-dollar commercial narrative and redirect the aging population toward what the evidence actually supports: physical exercise, specifically resistance training.
Study at a Glance: Ceglia et al., AJCN 2026
- Lead AuthorDr. Lisa Ceglia, Associate Professor, Tufts University School of Medicine
- JournalThe American Journal of Clinical Nutrition, DOI: 10.1016/j.ajcnut.2026.101257
- Participants141 healthy adults aged 65+, greater Boston area
- DesignFactorial randomized controlled trial (placebo-controlled, double-blind)
- InterventionsWhey protein capsules and/or potassium bicarbonate (antacid component)
- Primary FindingNo significant gain in muscle mass or strength from whey protein alone
- Co-investigatorProf. Bess Dawson-Hughes, HNRCA Senior Scientist, Tufts School of Medicine
The trial enrolled 141 healthy adults aged sixty-five and above from the greater Boston area. Lead author Dr. Lisa Ceglia, an endocrinologist and associate professor at Tufts University School of Medicine and a researcher at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA), designed the study alongside her colleague Professor Bess Dawson-Hughes. The team divided participants into groups: some received capsules of whey powder, others a placebo, and yet others received potassium bicarbonate alongside or instead of the whey supplement. The potassium bicarbonate element addressed a related biochemical hypothesis about acid accumulation in aging bodies. Whey was selected because it is derived from milk and is exceptionally rich in leucine, an amino acid that effectively activates the cellular signaling pathways responsible for building muscle. If any protein supplement were going to produce gains, the scientists reasoned, it would be this one.
The results, however, showed no statistically significant improvement in muscle mass or strength among participants who received whey protein compared to those who did not. As long as individuals were already meeting the recommended daily protein intake — which most older adults in the United States currently do — adding more protein in supplement form moved the needle on nothing that mattered clinically. “Older adults are better off hitting the gym,” Dr. Ceglia said plainly after the publication, cutting through the marketing noise that has surrounded protein supplementation for decades.
The Biology of Muscle Loss
To understand why this finding matters so profoundly, it helps to understand what is actually happening inside the aging body. The process of muscle decline does not begin dramatically at retirement age. It begins, almost imperceptibly, around the age of forty. At that point the kidneys start to lose their efficiency at excreting acid produced by ordinary metabolic processes. The body, instinctively trying to maintain its internal chemical balance, compensates by drawing on muscle tissue as a source of base compounds that neutralize the excess acid — much the way baking soda neutralizes vinegar. Over years and decades this low-level acid buffering silently erodes the very muscle that older adults are trying to protect.
This age-related muscle loss has a clinical name: sarcopenia. It is defined by the progressive decline in skeletal muscle mass, strength, and physical function. The epidemiological picture is sobering. According to data compiled across community-based studies, sarcopenia currently affects between ten and sixteen percent of the global elderly population, with rates climbing sharply with age. Among adults between sixty and seventy years old the prevalence sits at roughly five to thirteen percent. By the time individuals reach eighty years or older, that figure escalates to approximately fifty percent. In long-term care settings, where the frailest older adults reside, prevalence can exceed thirty percent even in those under eighty-five.
The consequences of sarcopenia extend far beyond the inconvenience of physical weakness. A 2025 review published in Metabolism: Clinical and Experimental summarized the clinical stakes clearly: sarcopenia dramatically increases the risk of falls, fractures, hospitalization, and loss of independent living. In the context of sepsis, older adults with sarcopenia face in-hospital mortality rates approaching fifty percent. These are not abstract statistics. They represent the lived reality of hundreds of millions of people who are aging, and who are actively looking for tools to hold on to their strength, their mobility, and their autonomy.
Protein alone doesn’t equate to muscle strength. Older adults who are already meeting recommended intake are better off hitting the gym than reaching for a supplement jar.
— Dr. Lisa Ceglia, Lead Author, Tufts University / AJCN 2026Why Whey Was the Best Candidate — And Still Failed
The Tufts team did not choose whey protein arbitrarily. Within the universe of protein supplements, whey enjoys a reputation built on genuine biochemical logic. It is a complete protein, meaning it contains all nine essential amino acids that the human body cannot synthesize independently. Among those amino acids, leucine occupies a singular position. Research has established for years that leucine acts almost like a molecular switch, activating the mTOR signaling pathway that initiates muscle protein synthesis. When muscle is damaged by exercise, leucine effectively tells the body to begin rebuilding. This is why whey has been the dominant choice in sports nutrition for decades, and why the researchers deemed it the supplement most likely to produce measurable results in an elderly population.
The problem, as the trial revealed, is that biological plausibility does not automatically translate into clinical outcome. The mTOR pathway may respond well to leucine in younger, protein-deficient individuals whose muscle-building machinery is working efficiently. In aging bodies, however, the situation is considerably more complicated. The muscle protein synthesis response to dietary protein is blunted with age — a phenomenon scientists call “anabolic resistance.” Older muscles simply do not respond to protein intake with the same vigour they once did. Adding more dietary protein on top of an already adequate intake does not bypass this resistance; it simply delivers more of something the body has already reached its ceiling for utilizing.
Past research had come tantalizingly close to suggesting protein supplementation works. Earlier studies showed that whey supplements could increase muscle protein synthesis rates in controlled short-term measurements and that they appeared to build lean tissue in some subgroups. What was missing, and what the Tufts trial was specifically designed to resolve, was whether these transient biochemical signals translated into real, durable gains in the muscle health of ordinary older adults living their ordinary lives over a meaningful period of time. The answer, in a properly powered, placebo-controlled trial, was no.
The Broader Research Picture
The Tufts study does not stand alone. It lands in the context of a growing body of literature that has been quietly complicating the whey protein narrative for years. A systematic review and meta-analysis published in Clinical Nutrition in 2024, which searched PubMed, EMBASE, the Cochrane Library, and Scopus for randomized controlled trials conducted through June of that year, examined the impact of whey protein supplementation on muscle strength, physical performance, and body composition in older adults. The authors found that whey protein supplementation may show a modest positive effect on appendicular skeletal muscle mass and lower body strength — but only when combined with resistance training. Without exercise in the picture, the evidence for supplementation producing clinically meaningful gains dissolves.
A 2023 meta-analysis published in the journal Nutrients examined seven randomized clinical trials involving 591 participants, all of whom had sarcopenia, and assessed the effect of whey protein supplementation during resistance exercise training. The pooled findings showed a small but statistically significant benefit in appendicular muscle index (SMD of 0.24; 95% CI, 0.05 to 0.42; p=0.01) and a meaningful improvement in handgrip strength of approximately 2.31 kilograms when protein supplementation accompanied structured exercise. The critical qualifier in that sentence is “accompanied.” Exercise was not incidental to those results; it was the engine that made the difference. Protein was, at best, a modest accelerant applied to an already firing machine.
A separate 2023 meta-analysis in Nutrients, focused specifically on whey protein, leucine, and vitamin D supplementation in sarcopenic patients, found that without a physical exercise program combined with the nutritional intervention, there were no significant differences between experimental and control groups in grip strength or on the Short Physical Performance Battery (SPPB) score. Appendicular muscle mass did show improvement in the supplemented group, suggesting some tissue-level effect, but this did not translate into meaningful functional gains in the absence of exercise. These patterns are consistent across the literature with a striking regularity that should inform clinical practice and public health messaging.
A Billion-Dollar Industry Built on Incomplete Evidence
The commercial backdrop against which this science is playing out is extraordinary in scale. The global whey protein market was valued at approximately $9.68 billion in 2025 and is projected to reach $17.5 billion by 2033, growing at a compound annual growth rate of 7.5 percent. The broader protein supplements market, of which whey is the dominant component, was valued at $28.52 billion in 2024 and is expected to nearly double to $58.65 billion by 2033. North America alone accounts for more than 38 percent of global revenue, with the United States as the single largest market. Whey protein concentrates lead the product category, and sports nutrition applications account for a significant share — though food manufacturers have dramatically expanded their use of protein fortification in mainstream consumer products precisely to reach non-athletic demographics, including older adults.
This is not a cynical industry making baseless claims. The underlying science that whey protein supports muscle protein synthesis is real. The problem is one of context and population specificity. The studies that initially established whey’s muscle-building credentials were conducted predominantly in younger individuals, in people with inadequate protein intake, or in experimental conditions that included resistance exercise. Marketing translated this nuanced, conditional evidence into something far simpler and more commercially useful: protein builds muscle. That translation is not wrong in all contexts. But it is deeply misleading when applied to healthy older adults who are already eating enough protein and are not engaging in strength training.
Researchers and clinicians have been gently pushing back on this oversimplification for years. The Tufts 2026 trial is the most direct, well-powered refutation yet, and it carries particular weight because it studied exactly the population at whom much of the protein-fortified food marketing is implicitly aimed. When the target audience is older adults worried about sarcopenia, the evidence now clearly says: a fortified latte or a protein-enriched yogurt is not your answer.
The mTOR pathway responds to leucine in young, protein-deficient muscles. In aging bodies facing anabolic resistance, adding more of what the body can no longer efficiently use changes very little.
— Analysis of existing literature on anabolic resistance in aged skeletal muscleWhat the Science Does Support
The Tufts findings do not leave older adults without hope; they redirect hope toward what actually works. The consistent signal across the research literature is that resistance exercise — also called strength training or weight training — is the most effective intervention available for preserving and even rebuilding muscle in older adults. Resistance exercise activates the same anabolic pathways that protein is supposed to stimulate, but it does so through a mechanism that aging muscle tissue has not lost its ability to respond to: mechanical loading. When muscles are subjected to progressive resistance, they receive a signal to adapt and grow that overrides the anabolic resistance that blunts the dietary protein response.
The World Health Organization recommends that adults aged sixty-five and over engage in muscle-strengthening activities involving major muscle groups at least twice per week, in addition to a minimum of 150 to 300 minutes of moderate-intensity aerobic activity. Research published across multiple exercise intervention trials has shown that even previously sedentary older adults who begin a structured resistance training program can achieve meaningful gains in muscle mass, strength, and functional capacity over twelve to twenty-four weeks. The improvements are clinically significant: better balance, reduced fall risk, improved ability to rise from a chair without assistance, and enhanced capacity to perform the activities of daily life independently.
The role of protein in this picture is not irrelevant, but it is subordinate to exercise and context-dependent. The current recommended daily allowance for protein sits at 0.8 grams per kilogram of body weight. A substantial body of research, including work from Tufts-affiliated scientists, suggests that older adults may benefit from somewhat higher intake — in the range of 1.0 to 1.2 grams per kilogram — particularly when engaging in resistance training. But this recommendation concerns baseline dietary intake from real food, not supplementation on top of an already adequate diet. Chicken, fish, eggs, legumes, dairy, and other whole food protein sources provide the amino acids needed for muscle maintenance alongside the broader nutritional matrix that supplements cannot replicate.
Acid, Alkali, and the Other Finding
The Tufts trial also tested the potassium bicarbonate hypothesis, examining whether neutralizing the body’s increasing acid load through an alkaline supplement could help preserve muscle by removing the biochemical impetus for muscle tissue breakdown. The rationale was compelling: if the body is breaking down muscle to buffer dietary acid, and if an alkaline supplement can take on that buffering function instead, perhaps muscle wasting could be slowed independently of protein intake or exercise. The team included this arm precisely because earlier research, including some from the HNRCA itself, had suggested acid-base balance plays a meaningful role in muscle physiology in aging adults.
The outcome on this front was similarly inconclusive for muscle mass and strength outcomes. While potassium bicarbonate has well-established effects on urinary acid excretion and bone health markers, its direct contribution to muscle preservation in this trial did not reach statistical significance for the primary outcomes examined. This negative result is scientifically important in its own right. It rules out a plausible alternative pathway and reinforces the conclusion that the biology of muscle aging is more complex, and more resistant to simple supplementary interventions, than either the protein or alkali hypotheses assumed.
Implications for Clinicians, Caregivers, and Patients
For physicians, dietitians, and geriatric care specialists, the Tufts findings offer clear clinical guidance. When older patients report taking whey protein supplements to prevent muscle loss, clinicians can now refer them to a high-quality randomized controlled trial demonstrating that the supplement, absent concurrent resistance training and in the context of adequate dietary protein, is unlikely to deliver the expected benefit. The conversation can then be redirected toward exercise prescription, which has a robust evidence base and no meaningful side effects for most older adults when introduced appropriately and progressively.
For caregivers and family members supporting older relatives, the practical message is similarly grounded. The money spent on protein powders, fortified shakes, and enhanced foods — a category that can impose a non-trivial monthly financial cost on fixed-income households — would in most cases be better allocated toward a gym membership, a personal trainer, a resistance band kit, or enrollment in a community fitness class designed for older adults. Many such programs now exist specifically for seniors and have been shown in multiple studies to be safe, effective, and socially beneficial as well as physically transformative.
For older adults themselves, the message is both honest and genuinely encouraging. The body does not lose the capacity to respond to exercise at sixty-five, seventy, or even eighty. The machinery for muscle adaptation remains intact in ways that the machinery for anabolic response to dietary protein does not. Studies have demonstrated strength gains in supervised resistance training programs among adults in their eighties and even nineties. The path to muscle health in later life runs through the weight room, not the supplement aisle.
Limitations and the Ongoing Science
Honest reporting of this trial requires acknowledging what it does not prove. The study enrolled 141 participants from a relatively homogeneous geographic area. It examined healthy older adults, meaning the findings may not apply directly to individuals who are already significantly protein-deficient, clinically malnourished, or suffering from advanced sarcopenia with very low baseline muscle mass. In populations with genuine nutritional deficiency, protein supplementation remains an important therapeutic tool. The 2024 systematic review in Clinical Nutrition and the earlier 2023 meta-analysis in Nutrients both suggested conditional benefits in subgroups, particularly sarcopenic individuals engaged in resistance training, that the Tufts trial was not designed to capture.
Additionally, the study examined whey protein specifically. Other protein sources — soy, casein, pea protein, blended formulations enriched with leucine and vitamin D — may have different biological profiles that the trial did not assess. A 2021 randomized controlled trial examining an enriched protein drink combining whey with leucine and vitamin D during a 13-week lifestyle intervention in older adults with obesity and type 2 diabetes found some evidence of benefit in preserving lean mass during caloric restriction, highlighting that context, combination, and population characteristics all modulate outcomes in ways that no single trial can fully capture. The science, as it always does, continues to evolve.
A clinical trial registered with ClinicalTrials.gov at the Federal University of Uberlândia in Brazil (NCT05862779) is currently investigating the combined effects of omega-3 fatty acid and whey protein supplementation on lean mass and strength in older adults performing resistance exercise, with estimated completion in 2026. Results from such trials will help fill in the remaining evidence gaps and may reveal whether specific nutritional combinations alongside structured training produce additive effects that protein alone does not.
A Reckoning With the Supplement Paradigm
The deeper question raised by the Tufts trial extends well beyond whey protein. It touches the broader cultural paradigm in which supplements are positioned as the primary vehicle for health management, particularly as people age. The supplement industry — of which protein products are only one category — operates in a regulatory environment far more permissive than pharmaceuticals, where claims can be made on the basis of limited evidence and withdrawn only when harm is established. The result is a marketplace in which billions of dollars flow toward products whose benefits, when tested rigorously in real-world populations, frequently do not hold up to scrutiny.
This is not a counsel of despair. It is a counsel of precision. The evidence base for nutrition science is genuinely complex, and the Tufts study does not render protein nutrition unimportant to aging health. Adequate dietary protein intake remains essential. Meeting the recommended intake through whole foods, ensuring that protein is distributed appropriately across meals, and maintaining overall dietary quality are all meaningful contributors to muscle health over time. What the study dismantles is the specific and commercially convenient idea that older adults can purchase their way out of sarcopenia with a scoop of powder stirred into their morning coffee.
The trajectory of the global aging population makes this reckoning increasingly urgent. The United Nations projects that the number of people aged sixty-five and over will more than double globally between 2020 and 2050, reaching 1.5 billion. The burden of sarcopenia, which already costs the United States an estimated $18.5 billion annually in direct healthcare expenditure (based on 2000 projections that have almost certainly grown significantly since), will scale accordingly unless effective prevention strategies are widely adopted. Redirecting older adults from passive supplement consumption to active exercise engagement is not merely a correction of a scientific misunderstanding. It is a public health imperative.
The whey protein industry will adapt, as industries do. There is already a pivot underway in some marketing narratives toward framing protein supplementation as a complement to exercise rather than a standalone solution. That framing is more accurate, and it reflects the direction in which the evidence genuinely points. For individuals who find it difficult to meet daily protein targets through food alone, or who are recovering from illness, surgery, or significant caloric restriction, well-formulated protein supplements remain a reasonable dietary tool. But for the healthy older adult standing in the supplement aisle, looking at a tub of whey powder and wondering whether it will keep them strong enough to stay independent, the most important message from Tufts 2026 is this: pick up the weights, not just the powder.
References & Sources
- Ceglia L, Konieczynski E, Danico E, Trinquart L, Koethe B. Independent effects of whey protein and alkali supplementation on muscle health in healthy older adults: factorial randomized controlled trial. The American Journal of Clinical Nutrition. 2026. DOI: 10.1016/j.ajcnut.2026.101257
- Tufts Now. In Older Adults, Adding Whey Protein Doesn't Make More Muscle. May 8, 2026. now.tufts.edu
- MedicalXpress. In older adults, adding whey protein doesn't make more muscle. May 11, 2026. medicalxpress.com
- Cuyul-Vásquez I et al. Effectiveness of Whey Protein Supplementation during Resistance Exercise Training on Skeletal Muscle Mass and Strength in Older People with Sarcopenia. Nutrients. 2023;15(15):3424. DOI: 10.3390/nu15153424
- Chang MC, Choo YJ. Effects of Whey Protein, Leucine, and Vitamin D Supplementation in Patients with Sarcopenia: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(3):521. PMC
- Clinical Nutrition. Effectiveness of whey protein supplementation on muscle strength and physical performance of older adults: A systematic review and meta-analysis. 2024. clinicalnutritionjournal.com
- GlobalRPH. Hidden Crisis: Why Sarcopenia Treatment Matters More Than You Think in 2025. December 2025. globalrph.com
- Petermann-Rocha F et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13:86–99. Wiley
- PMC / NIH. Sarcopenia: Current Insights into Molecular Mechanisms, Diagnostics, and Emerging Interventional Approaches. 2025. pmc.ncbi.nlm.nih.gov
- Grand View Research. Whey Protein Market Size, Share & Trends Analysis Report, 2025–2033. grandviewresearch.com
- Precedence Research. Whey Protein Market Size, Share, and Trends 2025–2034. precedenceresearch.com
- ClinicalTrials.gov. Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults. NCT05862779. clinicaltrials.gov
- NCBI/PMC. Effect of an Enriched Protein Drink on Muscle Mass and Glycemic Control during Combined Lifestyle Intervention in Older Adults with Obesity and Type 2 Diabetes. 2021. pmc.ncbi.nlm.nih.gov
- ARIC Cohort Study. Sarcopenia Incidence From Age 65 to 90+ Years, 2011–2023. pmc.ncbi.nlm.nih.gov
0 Comments